Codexis, Inc. (CDXS) financial statements (2022 and earlier)

Company profile

Business Address 200 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 286 - Industrial Organic Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments116,797119,189129,506139,748149,11771,51675,649
Cash and cash equivalents116,797119,189129,506139,748149,11771,51675,649
Restricted cash and investments600   600  
Receivables37,65248,47136,35927,73529,28826,59726,413
Inventory, net of allowances, customer advances and progress billings1,1601,0841,0781,029964737686
Inventory1,1601,0841,0781,029964737686
Capitalized contract cost5670865890130172
Other undisclosed current assets5,6235,2985,3664,9934,3643,9533,578
Total current assets:161,888174,112172,395173,563184,423102,933106,498
Noncurrent Assets
Finance lease, right-of-use asset17436894119145170
Operating lease, right-of-use asset44,09519,47820,12420,75821,38221,99622,599
Property, plant and equipment21,34516,12411,23210,3969,6757,2896,822
Intangible assets, net (including goodwill)3,2413,2413,2413,2413,2413,2413,241
Goodwill3,2413,2413,2413,2413,2413,2413,241
Restricted cash and investments1,5191,5191,5191,5191,0621,0621,062
Other noncurrent assets276271301249294353391
Other undisclosed noncurrent assets14,00212,7633,4302,3501,4501,0001,000
Total noncurrent assets:84,49553,43939,91538,60737,22335,08635,285
TOTAL ASSETS:246,383227,551212,310212,170221,646138,019141,783
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities26,69228,24919,10518,03820,53016,34614,559
Accounts payable2,9953,2813,1643,5692,9702,4992,637
Accrued liabilities12,57815,9279,0829,51610,2727,5706,943
Employee-related liabilities11,1199,0416,8594,9537,2886,2774,979
Deferred revenue2,5862,4492,3131,8971,8241,5961,903
Other undisclosed current liabilities4,0932,7822,6722,6182,6272,5542,482
Total current liabilities:33,37133,48024,09022,55324,98120,49618,944
Noncurrent Liabilities
Long-term debt and lease obligation43,56120,21820,99221,70122,32423,00123,665
Operating lease, liability43,56120,21820,99221,70122,32423,00123,665
Liabilities, other than long-term debt5,0604,7984,4554,1774,2383,7214,388
Deferred revenue3,7493,7473,1662,9002,9672,4603,142
Other liabilities1,3111,0511,2891,2771,2711,2611,246
Total noncurrent liabilities:48,62125,01625,44725,87826,56226,72228,053
Total liabilities:81,99258,49649,53748,43151,54347,21846,997
Stockholders' equity
Stockholders' equity attributable to parent164,391169,055162,773163,739170,10390,80194,786
Common stock6666666
Additional paid in capital552,083546,557542,519539,220536,516453,294451,185
Accumulated deficit(387,698)(377,508)(379,752)(375,487)(366,419)(362,499)(356,405)
Total stockholders' equity:164,391169,055162,773163,739170,10390,80194,786
TOTAL LIABILITIES AND EQUITY:246,383227,551212,310212,170221,646138,019141,783

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues24,50136,76925,45318,03221,03318,38514,967
Cost of revenue
(Cost of Goods and Services Sold)
(6,806)(6,867)(4,318)(4,218)(5,860)(3,642)(1,699)
Gross profit:17,69529,90221,13513,81415,17314,74313,268
Operating expenses(28,080)(28,572)(25,621)(22,969)(19,097)(20,807)(19,375)
Operating income (loss):(10,385)1,330(4,486)(9,155)(3,924)(6,064)(6,107)
Nonoperating income (expense)2631,0242298912(11)70
Investment income, nonoperating3541206177433957
Other nonoperating income (expense)22898323(88)(31)(50)13
Interest and debt expense      (1)
Other undisclosed income from continuing operations before equity method investments, income taxes      1
Income (loss) from continuing operations before income taxes:(10,122)2,354(4,257)(9,066)(3,912)(6,075)(6,037)
Income tax expense(68)(110)(8)(2)(8)(19)(307)
Net income (loss) available to common stockholders, diluted:(10,190)2,244(4,265)(9,068)(3,920)(6,094)(6,344)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(10,190)2,244(4,265)(9,068)(3,920)(6,094)(6,344)
Comprehensive income (loss), net of tax, attributable to parent:(10,190)2,244(4,265)(9,068)(3,920)(6,094)(6,344)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: